LEXINGTON, Mass.--(BUSINESS WIRE)--Synageva BioPharma Corp., (“Synageva”) (NASDAQ:GEVA) a clinical stage biopharmaceutical company developing therapeutic products for rare disorders announced today that it will be presenting at the upcoming Lazard Capital Markets 8th Annual Healthcare Conference, which is being held Nov. 15-16, at The Pierre Hotel in New York City.
